Boiron (BOI.PA)

Executive Summary

Boiron is a French pharmaceutical company focused on the manufacturing and global commercialization of homeopathic products. With a history dating back to 1932 and a presence in Europe and North America, the company markets a wide range of homeopathic medicines derived from natural substances. Its pipeline includes five drug candidates, though recent clinical trials have been completed or terminated without clear progression toward regulatory submission. The company faces ongoing skepticism regarding the scientific basis of homeopathy, which limits its growth prospects. Nonetheless, Boiron maintains a stable commercial product portfolio and continues to operate as a publicly traded entity on Euronext Paris.

Upcoming Catalysts (preview)

• TBDPotential European regulatory update on homeopathic products30% success
• TBDLaunch of a new homeopathic product in North America40% success
• TBDAnnual earnings report and strategic update60% success